Company / Cash & Equivalents
Zeo ScientifiX, Inc. Cash & Equivalents History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$108.6K
FY2021
5-year range
$108.6K / $590.8K
FY2018-FY2021
Trend
-81.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $132,557 to $108,570 over the past 2 years.
Based on SEC 10-K filings.
$108,570 in FY2021 with a 3-year CAGR of +36.2%.
Declined from $132,557 to $108,570 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +36.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +36.2%, indicating consistent growth.
- In FY2021, cash & equivalents decreased 81.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -40.46 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $108.6K | -81.6% |
| FY2020 | $590.8K | +345.7% |
| FY2019 | $132.6K | +208.2% |
| FY2018 | $43.0K | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |